During the past decade, Universitätsklinikum Erlangen, Neurologische klinik conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsklinikum Erlangen, Neurologische klinik" #1 sponsor was "Biogen" with 1 trials, followed by "D-Pharm Ltd." with 1 trials sponsored, "Institut de Recherches Internationales Servier" with 1 trials sponsored, "Ipsen" with 1 trials sponsored and "PhotoThera, Inc" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Erlangen, Neurologische klinik" #1 collaborator was "ADIR, a Servier Group company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Erlangen, Neurologische klinik" are "Acute Ischemic Stroke" (2 trials), "Cerebral Hemorrhage" (1 trials), "Cervical Dystonia" (1 trials), "Embolic Stroke of Undetermined Source" (1 trials) and "Fabry Disease" (1 trials). Many other conditions were trialed in "Universitätsklinikum Erlangen, Neurologische klinik" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Erlangen, Neurologische klinik" are "Drug" (3 trials), "Procedure" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Best medical treatment" (1 trials), "Botulinum toxin type A" (1 trials), "DP-b99" (1 trials) and "Decompressive craniectomy (DC) and best medical treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Erlangen, Neurologische klinik" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Erlangen, Neurologische klinik". 1 are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Universitätsklinikum Erlangen, Neurologische klinik, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Erlangen, Neurologische klinik, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".